Area of research
Oncology · Immunology
Research interest
Research interests include Cell biology, Experimental autoimmune encephalomyelitis, Immunology, Neuroinflammation, PI3K/AKT/mTOR pathway, and Cancer research.
MicroRNA‐31 is required for astrocyte specification
Protein Kinase CK2 Controls the Fate between Th17 Cell and Regulatory T Cell Differentiation
Protein kinase CK2 is important for the function of glioblastoma brain tumor initiating cells
Attenuation of PKR-like ER Kinase (PERK) Signaling Selectively Controls Endoplasmic Reticulum Stress-induced Inflammation Without Compromising Immunological Responses
Loss of SOCS3 in myeloid cells prolongs survival in a syngeneic model of glioma
Inhibition of Fucosylation Reshapes Inflammatory Macrophages and Suppresses Type II Collagen–Induced Arthritis
Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells
MHCII Is Required for -Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration
Therapeutic Efficacy of Suppressing the JAK/STAT Pathway in Multiple Models of Experimental Autoimmune Encephalomyelitis
The Interdependent, Overlapping, and Differential Roles of Type I and II IFNs in the Pathogenesis of Experimental Autoimmune Encephalomyelitis
CD5 enhances Th17‐cell differentiation by regulating IFN‐γ response and RORγt localization
Lithium Controls Central Nervous System Autoimmunity through Modulation of IFN-γ Signaling